Agilent 1200 Infinity Series: The best LC value for any application or budget
Agilent Product Profile
Name your budget or application – the Agilent 1200 Infinity Series has you covered. From our most affordable 1220 Infinity LC, starting at just $15,000, to the new industry standard 1260 Infinity LC to the most powerful 1290 Infinity LC, we have a solution that's right for you.
Agilent 1220 Infinity LC – Infinitely more affordable
- Agilent quality – affordable price
- HPLC and UHPLC compatibility – 600 bar and high-speed 80 Hz detector
- 1260/1290 Infinity LC technology – integrated design
Agilent 1260 Infinity LC – Infinitely more confident
- Raising the HPLC analytical standard – 600 bar, high-speed 80 Hz detector, up to 10x more sensitivity
- 100% HPLC compatibility – UHPLC capability
- HPLC price – UHPLC performance
Agilent 1290 Infinity LC – Infinitely more powerful
- Highest performance – by any measure
- Highest flexibility – in HPLC, RRLC, UHPLC
- UHPLC productivity – HPLC service costs
Visit www.agilent.com/chem/infinity to match an Infinity LC to your need or budget and learn more about the Infinity LC Series.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
